IL22 and type 1 diabetes mellitus: We adoptively transferred liver CD3-DX5-NK1.1+ cells from CD45.2 mice to CD45.1 T1D mice along with anti-IL-22 or isotype control antibodies on the 12th day after islet allograft transplantation.